Fig. 1From: Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conberceptSpectral-domain OCT 7 days after intravitreal injection of 0.05 mL of ziv-aflibercept (25 mg/mL) (a) or aflibercept (40 mg/mL) (b) in two rabbits’ right eyeBack to article page